公开(公告)号：US20230382899A1

公开(公告)日：2023-11-30

申请号：US18031380

申请日：2021-10-13

Applicant: QILU REGOR THERAPEUTICS INC.

Inventor： Wenge Zhong ,  Wei Guo ,  Zheng Jane Li ,  Xiawei Jiang ,  Pengyuan Chen

IPC: C07D405/14

CPC classification number: C07D405/14 ,  C07B2200/13

Abstract: Crystalline forms of Compound (A) represented by the following structural formula, and their corresponding pharmaceutical compositions, are disclosed. The crystalline forms are characterized by a variety of properties and physical measurements. Methods of preparing specific crystalline forms are also disclosed. The present disclosure also provides methods of treating or preventing diseases or conditions such as type 2 diabetes mellitus, pre-diabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and cardiovascular disease in a subject.